What drugs does ALPHA COGNITION make?

ALPHA COGNITION has 1 FDA-approved drugs including ZUNVEYL.

What therapeutic areas does ALPHA COGNITION focus on?

ALPHA COGNITION focuses primarily on Neurology.

← Back

Data updated: Mar 29, 2026

ALPHA COGNITION

Neurology

Pharma

ALPHA COGNITION is a pharmaceutical company focused on Neurology. Key products include ZUNVEYL.

2024

Since

Drugs

Trials

Approved (2yr)

Key Drugs

ZUNVEYL

benzgalantamine gluconate

CNS

Acetylcholinesterase 2 indications · 2024

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

ZUNVEYL 2024-07-26

Type 2 - New Active Ingredient and Type 3 - New Dosage Form

SEC Filings ProEarly access

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 100%

1 drugs

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

Bristol-Myers Squibb big-pharma

Neurology

ALPHA COGNITION

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (1)

Active (1)

Discontinued (0)

Company Info

ALPHA COGNITION

Set Alert

Key Drugs

Top Drug Revenues ProEarly access

Revenue Over Time ProEarly access

Recent Activity

Therapeutic Areas

Pipeline Forecast

Upcoming Trial Milestones ProEarly access

Patent Cliff ProEarly access

Competitors by Therapeutic Area

All Drugs (1)

Active (1)

Discontinued (0)

Company Info